Public Notice: Affirmative Action Order re. 9 Fentanyl Analogs

STATE OF WISCONSIN

CONTROLLED SUBSTANCES BOARD

---------------------------------------------------------------------------------------------------------------------

IN THE MATTER OF RULE-MAKING   :   AFFIRMATIVE ACTION

PROCEEDINGS BEFORE THE     :   ORDER OF THE

CONTROLLED SUBSTANCES BOARD   :   CONTROLLED SUBSTANCES BOARD

---------------------------------------------------------------------------------------------------------------------

FINDINGS

1. On December 7, 2023, the Department of Justice, Drug Enforcement Administration published its temporary amendment and scheduling order in the Federal Register adding the following 9 fentanyl related substances to schedule I of the federal Controlled Substances Act:



Meta-fluorofentanyl



Meta-fluoroisobutyryl fentanyl



Para-methoxyfuranyl fentanyl



3-furanyl fentanyl



2’,5’-dimethoxyfentanyl



Isovaleryl fentanyl



Ortho-fluorofuranyl fentanyl



Alpha’-methyl butyryl fentanyl



Para-methylcyclopropyl fentanyl

The scheduling action is effective December 7, 2023.

2. The Controlled Substances Board did not receive an objection to similarly listing the above 9 fentanyl related substances as schedule I controlled substances under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order listing the above 9 fentanyl related substances as schedule I controlled substances.

3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rulemaking, listing the above 9 fentanyl related substances as schedule I controlled substances.

ORDER

Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats the above 9 fentanyl related substances under chapter 961, Stats. by creating the following:

CSB 2.005 Addition of 9 Fentanyl Related Substances to Schedule I. (1) Section 961.14 (2) (nd) 3m., 10m., 11m., 12e., 12m., 12s., 16n., 17g., and 17r., are created to read:

961.14 (2) (nd) 3m. Alpha’-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

10m. 2’,5’-dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);

11m. 3-furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);

12e. Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

12m. Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);

12s. Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

16n. Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

17g. Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

17r. Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);

This order shall become effective upon publication in the Administrative Register. The order expires upon promulgation of a final rule.

Dated           _______________________

              Doug Englebert, Chair

              Controlled Substances Board